Effects of the nitric oxide donor, DEA/NO on cortical spreading depression
Cortical spreading depression (CSD) is a transient disruption of local ionic homeostasis that may promote migraine attacks and the progression of stroke lesions. We reported previously that the local inhibition of nitric oxide (NO) synthesis with Nω-nitro-L-arginine methyl ester (L-NAME) delayed mar...
Gespeichert in:
Veröffentlicht in: | Neuropharmacology 2003-06, Vol.44 (7), p.949-957 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 957 |
---|---|
container_issue | 7 |
container_start_page | 949 |
container_title | Neuropharmacology |
container_volume | 44 |
creator | Wang, M. Obrenovitch, T.P. Urenjak, J. |
description | Cortical spreading depression (CSD) is a transient disruption of local ionic homeostasis that may promote migraine attacks and the progression of stroke lesions. We reported previously that the local inhibition of nitric oxide (NO) synthesis with
Nω-nitro-L-arginine methyl ester (L-NAME) delayed markedly the initiation of the recovery of ionic homeostasis from CSD. Here we describe a novel method for selective, controlled generation of exogenous NO in a functioning brain region. It is based on microdialysis perfusion of the NO donor, 2-(N,N-diethylamino)-diazenolate-2-oxide (DEA/NO). As DEA/NO does not generate NO at alkaline pH, and as the brain has a strong acid-base buffering capacity, DEA/NO was perfused in a medium adjusted at alkaline (but unbuffered) pH. Without DEA/NO, such a microdialysis perfusion medium did not alter CSD. DEA/NO (1, 10 and 100 μM) had little effect on CSD by itself, but it reversed in a concentration-dependent manner the effects of NOS inhibition by 1 mM L-NAME. These data demonstrate that increased formation of endogenous NO associated with CSD is critical for subsequent, rapid recovery of cellular ionic homeostasis. In this case, the molecular targets for NO may be located either on brain cells to suppress mechanisms directly involved in CSD genesis, or on local blood vessels to couple flow to the increased energy demand associated with CSD. |
doi_str_mv | 10.1016/S0028-3908(03)00082-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73236991</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390803000820</els_id><sourcerecordid>73236991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-59f69655bfc65f4f4a3c50857936fd6bd4377fdf2b8aeefc7aeb80e406d06dee3</originalsourceid><addsrcrecordid>eNqFkMFKJDEQhoMoOs76CEouLgrbWul0p9MnGXRcFVkPu55DOqloZKYzJj2yvr3RGfQoFFQdvqr6-QjZZ3DCgInTvwClLHgL8gj4MQDIsoANMmKy4UUDotoko09kh-ym9JShSjK5TXZY2ZRClmJEbqbOoRkSDY4Oj0h7P0RvaPjvLVIb-hB_0Yvp5PTPHQ09NSEO3ugZTYuI2vr-gVrMY0o-9D_IltOzhHvrPib3l9N_51fF7d3v6_PJbWF4y4aibp1oRV13zojaVa7S3NQg66blwlnR2Yo3jbOu7KRGdKbR2EnACoTNhcjH5Ofq7iKG5yWmQc19Mjib6R7DMqmGl1y0LctgvQJNDClFdGoR_VzHV8VAvUtUHxLVuyEFXH1IzMOYHKwfLLs52q-ttbUMHK4BnbINF3VvfPriqhwBoM7c2YrDrOPFY1TJeOwNWh-zdGWD_ybKG6dRjcE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73236991</pqid></control><display><type>article</type><title>Effects of the nitric oxide donor, DEA/NO on cortical spreading depression</title><source>MEDLINE</source><source>ScienceDirect Freedom Collection (Elsevier)</source><creator>Wang, M. ; Obrenovitch, T.P. ; Urenjak, J.</creator><creatorcontrib>Wang, M. ; Obrenovitch, T.P. ; Urenjak, J.</creatorcontrib><description>Cortical spreading depression (CSD) is a transient disruption of local ionic homeostasis that may promote migraine attacks and the progression of stroke lesions. We reported previously that the local inhibition of nitric oxide (NO) synthesis with
Nω-nitro-L-arginine methyl ester (L-NAME) delayed markedly the initiation of the recovery of ionic homeostasis from CSD. Here we describe a novel method for selective, controlled generation of exogenous NO in a functioning brain region. It is based on microdialysis perfusion of the NO donor, 2-(N,N-diethylamino)-diazenolate-2-oxide (DEA/NO). As DEA/NO does not generate NO at alkaline pH, and as the brain has a strong acid-base buffering capacity, DEA/NO was perfused in a medium adjusted at alkaline (but unbuffered) pH. Without DEA/NO, such a microdialysis perfusion medium did not alter CSD. DEA/NO (1, 10 and 100 μM) had little effect on CSD by itself, but it reversed in a concentration-dependent manner the effects of NOS inhibition by 1 mM L-NAME. These data demonstrate that increased formation of endogenous NO associated with CSD is critical for subsequent, rapid recovery of cellular ionic homeostasis. In this case, the molecular targets for NO may be located either on brain cells to suppress mechanisms directly involved in CSD genesis, or on local blood vessels to couple flow to the increased energy demand associated with CSD.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/S0028-3908(03)00082-0</identifier><identifier>PMID: 12726826</identifier><identifier>CODEN: NEPHBW</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Animals ; Biological and medical sciences ; Cortical spreading depression ; Cortical Spreading Depression - drug effects ; Diethylamines - pharmacology ; Electroencephalography - drug effects ; Enzyme Inhibitors - pharmacology ; Extracellular Space - drug effects ; Extracellular Space - physiology ; High extracellular potassium ; Ionic homeostasis ; Male ; Medical sciences ; Microdialysis ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric oxide ; Nitric Oxide Donors - pharmacology ; Nitric oxide synthase ; Nitric Oxide Synthase - antagonists & inhibitors ; Nitric Oxide Synthase Type I ; Nitrogen Oxides ; NO donor ; Nω-nitro-L-arginine methyl ester (L-NAME) ; Rats ; Rats, Sprague-Dawley</subject><ispartof>Neuropharmacology, 2003-06, Vol.44 (7), p.949-957</ispartof><rights>2003 Elsevier Science Ltd</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-59f69655bfc65f4f4a3c50857936fd6bd4377fdf2b8aeefc7aeb80e406d06dee3</citedby><cites>FETCH-LOGICAL-c391t-59f69655bfc65f4f4a3c50857936fd6bd4377fdf2b8aeefc7aeb80e406d06dee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0028-3908(03)00082-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14732005$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12726826$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, M.</creatorcontrib><creatorcontrib>Obrenovitch, T.P.</creatorcontrib><creatorcontrib>Urenjak, J.</creatorcontrib><title>Effects of the nitric oxide donor, DEA/NO on cortical spreading depression</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>Cortical spreading depression (CSD) is a transient disruption of local ionic homeostasis that may promote migraine attacks and the progression of stroke lesions. We reported previously that the local inhibition of nitric oxide (NO) synthesis with
Nω-nitro-L-arginine methyl ester (L-NAME) delayed markedly the initiation of the recovery of ionic homeostasis from CSD. Here we describe a novel method for selective, controlled generation of exogenous NO in a functioning brain region. It is based on microdialysis perfusion of the NO donor, 2-(N,N-diethylamino)-diazenolate-2-oxide (DEA/NO). As DEA/NO does not generate NO at alkaline pH, and as the brain has a strong acid-base buffering capacity, DEA/NO was perfused in a medium adjusted at alkaline (but unbuffered) pH. Without DEA/NO, such a microdialysis perfusion medium did not alter CSD. DEA/NO (1, 10 and 100 μM) had little effect on CSD by itself, but it reversed in a concentration-dependent manner the effects of NOS inhibition by 1 mM L-NAME. These data demonstrate that increased formation of endogenous NO associated with CSD is critical for subsequent, rapid recovery of cellular ionic homeostasis. In this case, the molecular targets for NO may be located either on brain cells to suppress mechanisms directly involved in CSD genesis, or on local blood vessels to couple flow to the increased energy demand associated with CSD.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cortical spreading depression</subject><subject>Cortical Spreading Depression - drug effects</subject><subject>Diethylamines - pharmacology</subject><subject>Electroencephalography - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Extracellular Space - drug effects</subject><subject>Extracellular Space - physiology</subject><subject>High extracellular potassium</subject><subject>Ionic homeostasis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microdialysis</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide Donors - pharmacology</subject><subject>Nitric oxide synthase</subject><subject>Nitric Oxide Synthase - antagonists & inhibitors</subject><subject>Nitric Oxide Synthase Type I</subject><subject>Nitrogen Oxides</subject><subject>NO donor</subject><subject>Nω-nitro-L-arginine methyl ester (L-NAME)</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFKJDEQhoMoOs76CEouLgrbWul0p9MnGXRcFVkPu55DOqloZKYzJj2yvr3RGfQoFFQdvqr6-QjZZ3DCgInTvwClLHgL8gj4MQDIsoANMmKy4UUDotoko09kh-ym9JShSjK5TXZY2ZRClmJEbqbOoRkSDY4Oj0h7P0RvaPjvLVIb-hB_0Yvp5PTPHQ09NSEO3ugZTYuI2vr-gVrMY0o-9D_IltOzhHvrPib3l9N_51fF7d3v6_PJbWF4y4aibp1oRV13zojaVa7S3NQg66blwlnR2Yo3jbOu7KRGdKbR2EnACoTNhcjH5Ofq7iKG5yWmQc19Mjib6R7DMqmGl1y0LctgvQJNDClFdGoR_VzHV8VAvUtUHxLVuyEFXH1IzMOYHKwfLLs52q-ttbUMHK4BnbINF3VvfPriqhwBoM7c2YrDrOPFY1TJeOwNWh-zdGWD_ybKG6dRjcE</recordid><startdate>20030601</startdate><enddate>20030601</enddate><creator>Wang, M.</creator><creator>Obrenovitch, T.P.</creator><creator>Urenjak, J.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030601</creationdate><title>Effects of the nitric oxide donor, DEA/NO on cortical spreading depression</title><author>Wang, M. ; Obrenovitch, T.P. ; Urenjak, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-59f69655bfc65f4f4a3c50857936fd6bd4377fdf2b8aeefc7aeb80e406d06dee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cortical spreading depression</topic><topic>Cortical Spreading Depression - drug effects</topic><topic>Diethylamines - pharmacology</topic><topic>Electroencephalography - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Extracellular Space - drug effects</topic><topic>Extracellular Space - physiology</topic><topic>High extracellular potassium</topic><topic>Ionic homeostasis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microdialysis</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide Donors - pharmacology</topic><topic>Nitric oxide synthase</topic><topic>Nitric Oxide Synthase - antagonists & inhibitors</topic><topic>Nitric Oxide Synthase Type I</topic><topic>Nitrogen Oxides</topic><topic>NO donor</topic><topic>Nω-nitro-L-arginine methyl ester (L-NAME)</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, M.</creatorcontrib><creatorcontrib>Obrenovitch, T.P.</creatorcontrib><creatorcontrib>Urenjak, J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, M.</au><au>Obrenovitch, T.P.</au><au>Urenjak, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of the nitric oxide donor, DEA/NO on cortical spreading depression</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2003-06-01</date><risdate>2003</risdate><volume>44</volume><issue>7</issue><spage>949</spage><epage>957</epage><pages>949-957</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><coden>NEPHBW</coden><abstract>Cortical spreading depression (CSD) is a transient disruption of local ionic homeostasis that may promote migraine attacks and the progression of stroke lesions. We reported previously that the local inhibition of nitric oxide (NO) synthesis with
Nω-nitro-L-arginine methyl ester (L-NAME) delayed markedly the initiation of the recovery of ionic homeostasis from CSD. Here we describe a novel method for selective, controlled generation of exogenous NO in a functioning brain region. It is based on microdialysis perfusion of the NO donor, 2-(N,N-diethylamino)-diazenolate-2-oxide (DEA/NO). As DEA/NO does not generate NO at alkaline pH, and as the brain has a strong acid-base buffering capacity, DEA/NO was perfused in a medium adjusted at alkaline (but unbuffered) pH. Without DEA/NO, such a microdialysis perfusion medium did not alter CSD. DEA/NO (1, 10 and 100 μM) had little effect on CSD by itself, but it reversed in a concentration-dependent manner the effects of NOS inhibition by 1 mM L-NAME. These data demonstrate that increased formation of endogenous NO associated with CSD is critical for subsequent, rapid recovery of cellular ionic homeostasis. In this case, the molecular targets for NO may be located either on brain cells to suppress mechanisms directly involved in CSD genesis, or on local blood vessels to couple flow to the increased energy demand associated with CSD.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12726826</pmid><doi>10.1016/S0028-3908(03)00082-0</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3908 |
ispartof | Neuropharmacology, 2003-06, Vol.44 (7), p.949-957 |
issn | 0028-3908 1873-7064 |
language | eng |
recordid | cdi_proquest_miscellaneous_73236991 |
source | MEDLINE; ScienceDirect Freedom Collection (Elsevier) |
subjects | Animals Biological and medical sciences Cortical spreading depression Cortical Spreading Depression - drug effects Diethylamines - pharmacology Electroencephalography - drug effects Enzyme Inhibitors - pharmacology Extracellular Space - drug effects Extracellular Space - physiology High extracellular potassium Ionic homeostasis Male Medical sciences Microdialysis NG-Nitroarginine Methyl Ester - pharmacology Nitric oxide Nitric Oxide Donors - pharmacology Nitric oxide synthase Nitric Oxide Synthase - antagonists & inhibitors Nitric Oxide Synthase Type I Nitrogen Oxides NO donor Nω-nitro-L-arginine methyl ester (L-NAME) Rats Rats, Sprague-Dawley |
title | Effects of the nitric oxide donor, DEA/NO on cortical spreading depression |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T05%3A19%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20the%20nitric%20oxide%20donor,%20DEA/NO%20on%20cortical%20spreading%20depression&rft.jtitle=Neuropharmacology&rft.au=Wang,%20M.&rft.date=2003-06-01&rft.volume=44&rft.issue=7&rft.spage=949&rft.epage=957&rft.pages=949-957&rft.issn=0028-3908&rft.eissn=1873-7064&rft.coden=NEPHBW&rft_id=info:doi/10.1016/S0028-3908(03)00082-0&rft_dat=%3Cproquest_cross%3E73236991%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73236991&rft_id=info:pmid/12726826&rft_els_id=S0028390803000820&rfr_iscdi=true |